MA
Martin Auster
Chief Financial Officer

Martin Auster insider trades: Ventyx Biosciences (VTYX) stock sales

Chief Financial Officer, Ventyx Biosciences Last trade Apr 2, 2024 13 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2022
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Martin reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 2, 2024VTYX↓ Sell$8K
Sep 5, 2023VTYX↓ Sell$863K
Jul 25, 2023VTYX↓ Sell$995K
Jun 6, 2023VTYX↓ Sell$970K
Apr 25, 2023VTYX↓ Sell$1.1M
Apr 17, 2023VTYX↓ Sell$231K
Apr 4, 2023VTYX↓ Sell$646K
Dec 2, 2022VTYX↓ Sell$2.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VTYX insiders

Open-market trades in the last 12 months

About Martin Auster's insider trades

Martin Auster is Chief Financial Officer at Ventyx Biosciences (VTYX). Since Dec 2, 2022, Martin has reported no open-market purchases and 8 sales worth $7.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (7 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VTYX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.